1. Home
  2. CRI vs IVA Comparison

CRI vs IVA Comparison

Compare CRI & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$34.48

Market Cap

1.3B

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.98

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
IVA
Founded
1865
2011
Country
United States
France
Employees
N/A
84
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
CRI
IVA
Price
$34.48
$5.98
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$34.00
$16.20
AVG Volume (30 Days)
1.3M
282.9K
Earning Date
04-24-2026
03-30-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
N/A
EPS
2.53
N/A
Revenue
$2,898,426,000.00
N/A
Revenue This Year
$3.02
N/A
Revenue Next Year
$0.77
N/A
P/E Ratio
$13.63
N/A
Revenue Growth
1.91
N/A
52 Week Low
$23.38
$2.70
52 Week High
$44.44
$7.98

Technical Indicators

Market Signals
Indicator
CRI
IVA
Relative Strength Index (RSI) 42.71 44.20
Support Level $31.90 $5.79
Resistance Level $39.05 $6.48
Average True Range (ATR) 1.75 0.27
MACD -0.25 -0.06
Stochastic Oscillator 50.96 11.96

Price Performance

Historical Comparison
CRI
IVA

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: